O valor do nome!
Hoje o Jn brinda-nos com o destaque deste homem que, para minha infelicidade, conspurca o meu nome nas bocas e linguas ensalivadas deste País.
Confesso que me irrita que falem do "Avelino" em vez do "Ferreira Torrres", nome que o celebrizou devido às peripécias facistas e a um estranho assassínio do irmão.
Confesso que me irrita que falem do "Avelino" em vez do "Ferreira Torrres", nome que o celebrizou devido às peripécias facistas e a um estranho assassínio do irmão.
Na verdade este Avelino, deve ter uma das mais divertidas estórias de autarca de todo o País, e quando digo divertidas refiro-me ao aspecto trágico da coisa, que de tão irracional e opaca, só pode dar para rir.
Como sobre o "Ferreira Torres" pouco mais existe a dizer, entretantro fiquem com outros "avelinos":
cidade de Pedro Avelino
cidade de Avellino
provincia de Avellino
Clube de futebol Union Sportiva Avellino
Pai de Álvaro Cunhal - Avelino Cunhal
Caves Avelino Vegas
Santo Andrea Avellino
9 comentários:
Deixe lá Avelino
O nome que carrego também já foi usado por umas ricas peças...
Do mal o menos, agora se fosse Aníbal...
AMNM
Imagino ke sendo F. Torres um politico de uma aldeola, kal serão os trukes dos outros politicos de alto gabarito
não contando com trukes conhecidos
- pactos de silencio
- venda de batatas e outros bens
- construção de casas com o material das obras publicas
- bombas e bombinhas nos anos 70
- kedas de aviões com material desconhecido
.............................
Rakel p/ kando tiveres tempo- a noticia sobre akilo ke falamos há uns meses -celulas de embriões- , parece ter sido uma fraude , será ke afinal não estamos assim tão avançados ou a fraude é apenas nos metodos?!
Ob
Incoerente
Primeiro Avelino
O nome nunca é escolhido por nós e tem quase sempre uma boa história por trás. Mas nosso trajecto é de inteira responsabilidade nossa. E o teu não se confunde com o outro Avelino que faz a capa do JN.
Como sabes, tenho uma grande admiração por ti. Quem sabe o outro A ainda muda de nome.
Cara Cristina
Não sei ao que se refere.
Cristina
É disto que fala?
News of the Week
STEM CELLS:
Landmark Paper Has an Image Problem
Gretchen Vogel
New questions about scientific validity are dogging South Korean cloning researcher Woo-Suk Hwang and his colleagues. On 4 December, Hwang notified Science editors that a figure in online material that accompanies his group's heralded 2005 paper on the derivation of stem cells from cloned human embryos contained duplicate images. The problem follows close on the heels of Hwang's admission that, despite his previous denials, two members of his lab had donated oocytes for his group's experiments and others had been paid for their donations (Science, 2 December, p. 1402).
Katrina Kelner, Science deputy editor for life sciences, says it appeared that the duplicate panels were not part of the original submission but had been sent in response to a request for high-resolution images after the paper had been received. "From the information that we have so far, it seems that it was an honest mistake," she says. "We have no evidence that there was any intent to deceive."
In May 2005, Hwang and his colleagues reported that they had produced 11 new human embryonic stem (ES) cell lines that carried the genetic signature of patients with diabetes, spinal cord injury, or a genetic blood disorder (Science, 20 May, p. 1096). The paper not only seemed to validate the group's claim a year earlier that it had created a single cell line from a cloned human embryo, but it also reported a huge increase in efficiency for the technique. In the first paper, researchers said they produced one cell line from 230 tries, but in the second, they claimed they produced a cell line in about one of 15 attempts.
The figure in question is supposed to show patterns of expression for a range of ES cell markers in the 11 cell lines. But it contains four pairs of apparently duplicated images, even though they are labeled as showing different cell lines. Gerald Schatten of the University of Pittsburgh in Pennsylvania, who was the corresponding author on the paper and provided the high-resolution images to Science, declined to comment. A university spokesperson said that the university's office of research integrity had begun an investigation. Schatten and his lab members are cooperating, she said, "and are carefully going through the data we have access to to determine how it could have happened." She said Schatten would not comment during the investigation, which might last 6 months.
Rudolf Jaenisch of the Whitehead Institute for Biomedical Research in Cambridge, Massachusetts, says he still has confidence in the reported results. "This is an extremely important study, and I have no reason whatsoever to question any of the published data," he says.
Kelner says the journal will issue a correction once the editors are satisfied they understand what had happened.
é isto exactamente
o ke noticiaram hoje foi a total descredibilização do cientista , os recursos e os financiamentos
não fikei a perceber se as celulas não servem os efeitos ke se previam , ou se a burla da kestão esta nos financiamento e dadores...
basicamente se a expriencia valeu ou não a pena
Cristina
aqui vai a cópia do editorial da Science sobre o assunto.
O problema é de fraude cientifica.
Resumindo: Foi noticiado que este grupo tinha obtido 11 linhas celulares por transferencia nuclear ("tipo clonagem") quando na realidade só existe prova de 2 linhas celulares. Todas as outras são duplicações falsas. O bem da ciência é que possivel, na maioria dos casos, confirmar ou negar conclusões anteriores, porque tudo se baseia em resultados experimentais. Este é o aspecto mais nobre da ciência, a avaliação permanente por pares.
Published Online December 22, 2005
Science DOI: 10.1126/science.1124185
Science Express Index
Letters
Submitted on December 21, 2005
Accepted on December 22, 2005
Editorial Expression of Concern
Donald Kennedy 1*
1 Editor-in-Chief, Science, American Association for the Advancement of Science, 1200 New York Avenue NW, Washington, DC 20005, USA.
* To whom correspondence should be addressed.
Donald Kennedy , E-mail: dkennedy@aaas.org
The Report entitled "Patient-specific embryonic stem cells from human SCNT blastocysts" by W. S. Hwang et al. (Science 308, 1777-1783, 17 June 2005) reported the establishment of 11 human embryonic stem cell lines by somatic cell nuclear transfer of skin cells from patients with disease or injury into donated oocytes. Hwang and G. Schatten, the corresponding authors on the paper, have notified Science of their intention to retract the paper. Hwang has sent us some language that he intends to use in the retraction. We have requested more information from the authors as well as agreement from all the co-authors to retract the paper.
On 23 December 2005, the Seoul National University (SNU) Investigation Committee provided an interim report on their investigation of Woo Suk Hwang's research. The report stated that "the experimental data submitted to Science in support of 11 stem cell lines (DNA fingerprinting, microscopic photos, confirmation of teratomas, etc.) were all derived from 2 cell lines" and that "the Committee finds that the experimental data published in the 2005 Science paper were based on a deliberate manipulation, in other words a fabrication of research results." The report also states that "The Investigation Committee has submitted samples of cell lines 2 and 3 for DNA testing in order to determine their authenticity."
An earlier paper published in 2004 by Hwang and colleagues (Science 303, 1669-1674, 12 March 2004) attracted much attention as the first demonstration of the derivation of a pluripotent embryonic stem cell line from a cloned human blastocyst. Given the concerns raised about the 2005 paper, we are undertaking a careful review of the 2004 paper as well and expect to consult with outside advisors as needed. The SNU Investigation Committee announced that it has begun an investigation of this paper and of other work from the Hwang lab.
Science is publishing this expression of concern to alert our readers that serious concerns have been raised about the validity of the findings in these two papers. We are working with the authors and SNU to proceed with the retraction of the 2005 paper. We will provide more information on the 2004 paper as it becomes available.
The editors suggest the following related resources on Science sites:
In Science Magazine
Reports:
Patient-Specific Embryonic Stem Cells Derived from Human SCNT Blastocysts
Woo Suk Hwang, Sung Il Roh, Byeong Chun Lee, Sung Keun Kang, Dae Kee Kwon, Sue Kim, Sun Jong Kim, Sun Woo Park, Hee Sun Kwon, Chang Kyu Lee, Jung Bok Lee, Jin Mee Kim, Curie Ahn, Sun Ha Paek, Sang Sik Chang, Jung Jin Koo, Hyun Soo Yoon, Jung Hye Hwang, Youn Young Hwang, Ye Soo Park, Sun Kyung Oh, Hee Sun Kim, Jong Hyuk Park, Shin Yong Moon, and Gerald Schatten
Science 17 June 2005: 1777-1783 | Abstract » | Full Text » | Supporting Online Material » | Correction »
Reports:
Evidence of a Pluripotent Human Embryonic Stem Cell Line Derived from a Cloned Blastocyst
Woo Suk Hwang, Young June Ryu, Jong Hyuk Park, Eul Soon Park, Eu Gene Lee, Ja Min Koo, Hyun Yong Jeon, Byeong Chun Lee, Sung Keun Kang, Sun Jong Kim, Curie Ahn, Jung Hye Hwang, Ky Young Park, Jose B. Cibelli, and Shin Yong Moon
Science 12 March 2004: 1669-1674 | Abstract » | Full Text » | Supporting Online Material »
[url=http://kaufencialisgenerikade.com/]bestellen cialis[/url] cialis generika erfahrungen
[url=http://acquistocialisgenericoit.com/]cialis acquistare[/url] cialis vendita
[url=http://comprarcialisgenericoes.com/]precio cialis[/url] precio cialis
[url=http://achatcialisgeneriquefr.com/]cialis acheter[/url] commander cialis sur internet
[url=http://kaufencialisgenerikade.com/]generika cialis[/url] cialis
[url=http://acquistocialisgenericoit.com/]acquisto cialis[/url] cialis in farmacia
[url=http://comprarcialisgenericoes.com/]comprar cialis[/url] cialis
[url=http://achatcialisgeneriquefr.com/]achat cialis[/url] cialis moins cher
Enviar um comentário